Skip to main content

Advertisement

SpringerLink
Log in

Clinical depression, antidepressant use and risk of future cardiovascular disease

  • PSYCHIATRIC EPIDEMIOLOGY
  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

Many studies have shown that depression contributes to a higher risk of developing cardiovascular disease (CVD). Use of antidepressants and its association with CVD development has also been investigated previously but the results have been conflicting. Further, depression and use of antidepressants have been more widely studied in relation to coronary heart disease rather than stroke. A population-based cohort study consisting of 36,654 Swedish elderly twins was conducted with a follow-up of maximum 4 years. Information on exposures, outcomes and covariates were collected from the Swedish national patient registers, the Swedish prescribed drug registry and the Swedish twin registry. Depression and antidepressant use were both associated with CVD development. The risk was most pronounced among depressed patients who did not use antidepressants (HR 1. 48, CI 1.10–2.00). When assessing the two main CVD outcomes coronary heart disease and ischemic stroke separately, the predominant association was found for ischemic stroke while it was absent for coronary heart disease. The association between depression and stroke also remained significant when restricting to depression diagnoses occurring at least 10 years before baseline. The study supports that depression is a possible risk factor for development of CVD. Moreover, the hazard rate for CVD outcomes was highest among depressed patients who had not used antidepressants. The association with clinical depression is more marked in relation to stroke and disappears in relation to development of coronary heart disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Rutledge T, Reis SE, Olson MB, et al. Depression symptom severity and reported treatment history in the prediction of cardiac risk in women with suspected myocardial ischemia: the NHLBI-sponsored WISE study. Arch Gen Psychiatry. 2006;63:874–80.

    Article  PubMed  Google Scholar 

  2. Wassertheil-Smoller S, Shumaker S, Ockene J, et al. Depression and cardiovascular sequelae in postmenopausal women. The Women’s Health Initiative (WHI). Arch Intern Med. 2004;164:289–98.

    Article  PubMed  Google Scholar 

  3. Whooley MA. Depression and cardiovascular disease: healing the broken-hearted. JAMA. 2006;295:2874–81.

    Article  PubMed  CAS  Google Scholar 

  4. Whooley MA, de Jonge P, Vittinghoff E, et al. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA. 2008;300:2379–88.

    Article  PubMed  CAS  Google Scholar 

  5. Wouts L, Oude Voshaar RC, Bremmer MA, Buitelaar JK, Penninx BW, Beekman AT. Cardiac disease, depressive symptoms, and incident stroke in an elderly population. Arch Gen Psychiatry. 2008;65:596–602.

    Article  PubMed  Google Scholar 

  6. Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J. 2006;27:2763–74.

    Article  PubMed  Google Scholar 

  7. Pan A, Sun Q, Okereke OI, Rexrode KM, Hu FB. Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review. JAMA. 2011;306:1241–9.

    Article  PubMed  CAS  Google Scholar 

  8. Kendler KS, Gardner CO, Fiske A, Gatz M. Major depression and coronary artery disease in the Swedish twin registry: phenotypic, genetic, and environmental sources of comorbidity. Arch Gen Psychiatry. 2009;66:857–63.

    Article  PubMed  Google Scholar 

  9. Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M. ‘Vascular depression’ hypothesis. Arch Gen Psychiatry. 1997;54:915–22.

    Article  PubMed  CAS  Google Scholar 

  10. Janszky I, Ahnve S, Lundberg I, Hemmingsson T. Early-onset depression, anxiety, and risk of subsequent coronary heart disease: 37-year follow-up of 49,321 young Swedish men. J Am Coll Cardiol. 2010;56:31–7.

    Article  PubMed  Google Scholar 

  11. Stansfeld SA, Smith GD, Marmot M. Association between physical and psychological morbidity in the Whitehall II Study. J Psychosom Res. 1993;37:227–38.

    Article  PubMed  CAS  Google Scholar 

  12. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006;27:24–31.

    Article  PubMed  CAS  Google Scholar 

  13. Miwa K, Tanaka M, Okazaki S, et al. Association between interleukin-6 levels and first-ever cerebrovascular events in patients with vascular risk factors. Arterioscler Thromb Vasc Biol. 2013;33:400–5.

    Article  PubMed  CAS  Google Scholar 

  14. Leonard BE, Song C. Stress and the immune system in the etiology of anxiety and depression. Pharmacol Biochem Behav. 1996;54:299–303.

    Article  PubMed  CAS  Google Scholar 

  15. Marano G, Harnic D, Lotrionte M, et al. Depression and the cardiovascular system: increasing evidence of a link and therapeutic implications. Expert Rev Cardiovasc Ther. 2009;7:1123–47.

    Article  PubMed  Google Scholar 

  16. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry. 1998;55:580–92.

    Article  PubMed  CAS  Google Scholar 

  17. Roose SP. Treatment of depression in patients with heart disease. Biol Psychiatry. 2003;54:262–8.

    Article  PubMed  CAS  Google Scholar 

  18. Blanchette CM, Simoni-Wastila L, Zuckerman IH, Stuart B. A secondary analysis of a duration response association between selective serotonin reuptake inhibitor use and the risk of acute myocardial infarction in the aging population. Ann Epidemiol. 2008;18:316–21.

    Article  PubMed  Google Scholar 

  19. Hamer M, David Batty G, Seldenrijk A, Kivimaki M. Antidepressant medication use and future risk of cardiovascular disease: the Scottish Health Survey. Eur Heart J. 2011;32:437–42.

    Article  PubMed  CAS  Google Scholar 

  20. Smoller JW, Allison M, Cochrane BB, et al. Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women’s Health Initiative study. Arch Intern Med. 2009;169:2128–39.

    Article  PubMed  Google Scholar 

  21. Tata LJ, West J, Smith C, et al. General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction. Heart. 2005;91:465–71.

    Article  PubMed  CAS  Google Scholar 

  22. Kimmel SE, Schelleman H, Berlin JA, et al. The effect of selective serotonin re-uptake inhibitors on the risk of myocardial infarction in a cohort of patients with depression. Br J Clin Pharmacol. 2011;72:514–7.

    Article  PubMed  CAS  Google Scholar 

  23. Monster TB, Johnsen SP, Olsen ML, McLaughlin JK, Sorensen HT. Antidepressants and risk of first-time hospitalization for myocardial infarction: a population-based case-control study. Am J Med. 2004;117:732–7.

    Article  PubMed  CAS  Google Scholar 

  24. Sauer WH, Berlin JA, Kimmel SE. Selective serotonin reuptake inhibitors and myocardial infarction. Circulation. 2001;104:1894–8.

    Article  PubMed  CAS  Google Scholar 

  25. Sauer WH, Berlin JA, Kimmel SE. Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction. Circulation. 2003;108:32–6.

    Article  PubMed  CAS  Google Scholar 

  26. Meier CR, Schlienger RG, Jick H. Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction. Br J Clin Pharmacol. 2001;52:179–84.

    Article  PubMed  CAS  Google Scholar 

  27. O’Connor CM, Jiang W, Kuchibhatla M, et al. Antidepressant use, depression, and survival in patients with heart failure. Arch Intern Med. 2008;168:2232–7.

    Article  PubMed  Google Scholar 

  28. Zahradnik I, Minarovic I, Zahradnikova A. Inhibition of the cardiac L-type calcium channel current by antidepressant drugs. J Pharmacol Exp Ther. 2008;324:977–84.

    Article  PubMed  CAS  Google Scholar 

  29. Pacher P, Kecskemeti V. Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns? Curr Pharm Des. 2004;10:2463–75.

    Article  PubMed  CAS  Google Scholar 

  30. Ottervanger JP, Stricker BH, Huls J, Weeda JN. Bleeding attributed to the intake of paroxetine. Am J Psychiatry. 1994;151:781–2.

    PubMed  CAS  Google Scholar 

  31. Hergovich N, Aigner M, Eichler HG, Entlicher J, Drucker C, Jilma B. Paroxetine decreases platelet serotonin storage and platelet function in human beings. Clin Pharmacol Ther. 2000;68:435–42.

    Article  PubMed  CAS  Google Scholar 

  32. Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.

    Article  PubMed  Google Scholar 

  33. Medicinalstyrelsen K. International Statistical Classification of Diseases, Injuries and Causes of Death, 1955 revision adapted for indexing of hospitals. Stockholm; 1965.

  34. Socialstyrelsen. International Statistical Classification of Diseases, Injuries and Causes of Death, 1965 revision adapted for indexing of hospitals; 1968.

  35. Socialstyrelsen. Svensk version av International Classification of Diseases, Ninth Revision (ICD-9); 1987.

  36. Socialstyrelsen. Svensk version av International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10); 2010. Report No.: 2010-11-13.

  37. Therneau TM, Grambsch PM. Modelling Survival Data: extending the Cox model: Springer; 2000.

  38. Carlin JB, Galati JC, Royston P. A new framework for managing and analyzing multiply imputed data in Stata. Stata J. 2008;8:49–67.

    Google Scholar 

  39. Grobbee DE, Hoes AW. Confounding and indication for treatment in evaluation of drug treatment for hypertension. BMJ. 1997;315:1151–4.

    Article  PubMed  CAS  Google Scholar 

  40. Nabi H, Kivimaki M, Suominen S, Koskenvuo M, Singh-Manoux A, Vahtera J. Does depression predict coronary heart disease and cerebrovascular disease equally well? The Health and Social Support Prospective Cohort Study. Int J Epidemiol. 2010;39:1016–24.

    Article  PubMed  Google Scholar 

  41. Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA. 2003;289:3106–16.

    Article  PubMed  Google Scholar 

  42. van Melle JP, de Jonge P, Honig A, et al. Effects of antidepressant treatment following myocardial infarction. Br J Psychiatry. 2007;190:460–6.

    Article  PubMed  Google Scholar 

  43. Mead GE, Hsieh CF, Lee R, et al. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. Cochrane Database Syst Rev. 2012;11:CD009286.

    PubMed  Google Scholar 

  44. Witte TK, Timmons KA, Fink E, Smith AR, Joiner TE. Do major depressive disorder and dysthymic disorder confer differential risk for suicide? J Affect Disord. 2009;115:69–78.

    Article  PubMed  Google Scholar 

  45. Russ TC, Stamatakis E, Hamer M, Starr JM, Kivimaki M, Batty GD. Association between psychological distress and mortality: individual participant pooled analysis of 10 prospective cohort studies. BMJ. 2012;345:e4933.

    Article  PubMed  Google Scholar 

  46. Salmi P. Äldres behov av psykiatrisk vård och stöd; 2012 2012-02.

Download references

Acknowledgments

This work was funded by The Ministry for Higher Education, Heart and Lung Foundation No. 20070481. K.H. was supported by the Swedish Research Council (523-2006-972).

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Box 281, 17177, Stockholm, Sweden

    Iffat Rahman, Keith Humphreys, Anna Michaela Bennet, Erik Ingelsson, Nancy Lee Pedersen & Patrik Karl Erik Magnusson

Authors
  1. Iffat Rahman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Keith Humphreys
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anna Michaela Bennet
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Erik Ingelsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nancy Lee Pedersen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Patrik Karl Erik Magnusson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Iffat Rahman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rahman, I., Humphreys, K., Bennet, A.M. et al. Clinical depression, antidepressant use and risk of future cardiovascular disease. Eur J Epidemiol 28, 589–595 (2013). https://doi.org/10.1007/s10654-013-9821-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10654-013-9821-z

Keywords

Search

Navigation